Thus, the prevalence of cancer (81% in 430 cases) and the proportion of BRAF (83% in 293 mutation-positive specimens) were very high, compared to other studies (cancer prevalence of 15–35%) [8,10,11]. This evidence concerns the gene BRAF and cancer.